Concepedia

Publication | Open Access

CCTG IND 232: A phase II study of durvalumab with or without tremelimumab in patients with metastatic castration resistant prostate cancer (mCRPC)

DOIFull Paper Access

19

Citations

0

References

2019

Year

Sébastien J. Hotte, Eric Winquist, K.N. Chi, Susan Ellard, Srikala S. Sridhar, Urban Emmenegger, Muhammad Salim, Nayyer Iqbal, Christina Canil, C. Kollmannsberger,
Annals of Oncology

No additional data available for this publication yet. Check back later!